Gingivitis Treated With Chlorhexidine 0.12% Mouthwash in Young Adults
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of this study will evaluate the effectiveness of 0.12% chlorhexidine solution as an anti-inflammatory agent and reducing the presence of biofilm in young adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedFirst Submitted
Initial submission to the registry
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedFirst Posted
Study publicly available on registry
December 8, 2020
CompletedDecember 11, 2020
December 1, 2020
2.3 years
December 1, 2020
December 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plaque Index
Check the biofilm as Ainano \& Bay 1975 index, Higher levels means worse.
30 days
Secondary Outcomes (1)
Gingival Index
30 days
Study Arms (2)
Solution 1
ACTIVE COMPARATOR0.12% chlorhexidine
Solution 2
PLACEBO COMPARATORSaline solution
Interventions
the patients were randomly allocated into two groups of 15 individuals to rinse with antimicrobials twice a day for a period of four weeks. Group A, received 0.12% chlorhexidine antimicrobian in a vial previously identified as solution 1 and group B, received saline solution identified as solution 2.
Eligibility Criteria
You may qualify if:
- Presence of gingivitis
- Probing depth (PD) with maximum 3 mm
- Minimum of 20 teeth
- Age between 18 and 30 years old
You may not qualify if:
- Patients with periodontal disease (PD ≥ 4mm with clinical attachment loss)
- Diabetes
- Osteoporosis
- Pregnant or lactating females
- Smokers
- Users of immune suppressive medication
- Phenytoin or cyclosporine
- Calcium channel blockers
- Antibiotics
- Nonsteroidal anti-inflammatory drugs
- HIV+ or AIDS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal Fluminense
Nova Friburgo, Rio de Janeiro, 28625650, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Participant will receiver mouthwash solution with labeled number, they will not know which solution will inside. Care provider - The research that will collect clinical parameter wil be different for researcher that will do the treatment. Investigator will not have contact with treatment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
December 1, 2020
First Posted
December 8, 2020
Study Start
August 1, 2018
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
December 11, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share